Evaluation the Effect of Fenugreek Vaginal Cream on Vaginal Atrophy in Postmenopausal Wome
Not Applicable
- Conditions
- Atrophy Vaginal in post menopausal women.Postmenopausal Atrophic Vaginitis
- Registration Number
- IRCT2017010331705N2
- Lead Sponsor
- Vice chancellor for research, Ahwaz JundiShapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
inclusion criteria: Age between 45 to 65; Amenorrhea at less 12 month or have hormone test with FSH level more than 40 unit; Presenting symptom of vaginal atrophy; Have Sexual activity and single partner; Exclusion criteria; Vaginal infection? Genital Abnormalities? The use of Sex Hormones within the 8 weeks preceding studY; user of smoke and alcohol and etc; Genital Bleeding or spotting of unknown Cause; Use of Phytoestrogens such as Soy; Red clove; Fenugreek; Vitex within the last one Month.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of Maturity vaginal. Timepoint: Before and after eight weeks (end of intervention). Method of measurement: Vaginal smear.;Vaginal Atrophy. Timepoint: Before intervention, Two weeks after the intervention, Four weeks after intervention, Eight weeks after intervention. Method of measurement: Kupperman Index Questionnaire.;Vaginal PH. Timepoint: Before and after eight weeks (end of intervention). Method of measurement: By PH meter strips.
- Secondary Outcome Measures
Name Time Method Sexual function. Timepoint: Before and after intervention. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.;Temperament. Timepoint: Before and after intervention. Method of measurement: Temperament questionnaires.;Dyspareunia. Timepoint: Before intervention, Two weeks after the intervention, Four weeks after intervention, Eight weeks after intervention. Method of measurement: self-assessed 4-point scale of composite score.;Menopausal symptoms. Timepoint: Before intervention, 2, 4, 8 weeks after intervention. Method of measurement: Kupperman Index Questionnaire.;Severity of menopausal symptoms. Timepoint: Before intervention, 2, 4, 8 weeks after intervention. Method of measurement: Menopause Rating Scale (MRS) questionnaire.;Sexual satisfaction. Timepoint: Before and after intervention. Method of measurement: Larson's sexual satisfaction questioner.